Synonym
Ono-3805 sodium; Ono-3805; Ono 3805; Ono3805.
IUPAC/Chemical Name
sodium (S)-4-(2-(4-(1-(4-isobutylphenyl)ethoxy)-2,3-dimethylbenzamido)phenoxy)butanoate
InChi Key
MCEJXPXIKHUFRY-BQAIUKQQSA-M
InChi Code
InChI=1S/C31H37NO5.Na/c1-20(2)19-24-12-14-25(15-13-24)23(5)37-28-17-16-26(21(3)22(28)4)31(35)32-27-9-6-7-10-29(27)36-18-8-11-30(33)34;/h6-7,9-10,12-17,20,23H,8,11,18-19H2,1-5H3,(H,32,35)(H,33,34);/q;+1/p-1/t23-;/m0./s1
SMILES Code
O=C([O-])CCCOC1=CC=CC=C1NC(C2=CC=C(O[C@H](C3=CC=C(CC(C)C)C=C3)C)C(C)=C2C)=O.[Na+]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Related CAS#
119347-96-5 (Ono-3805 Free)
119347-91-0 (Ono-3805)
Preparing Stock Solutions
The following data is based on the
product
molecular weight
525.62
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Aggarwal S, Thareja S, Verma A, Bhardwaj TR, Kumar M. An overview on 5alpha-reductase inhibitors. Steroids. 2010 Feb;75(2):109-53. doi: 10.1016/j.steroids.2009.10.005. Review. PubMed PMID: 19879888.
2: Igarashi S, Inami H, Hara H, Koutoku H, Oritani H, Mase T. A novel class of inhibitors for human and rat steroid 5alpha-reductases: synthesis and biological evaluation of indoline and aniline derivatives. III. Chem Pharm Bull (Tokyo). 2000 Nov;48(11):1689-97. PubMed PMID: 11086897.
3: Takami H, Nonaka H, Kishibayashi N, Ishii A, Kase H, Kumazawa T. Synthesis of tricyclic compounds as steroid 5alpha-reductase inhibitors. Chem Pharm Bull (Tokyo). 2000 Apr;48(4):552-5. PubMed PMID: 10783077.
4: Takami H, Koshimura H, Kishibayashi N, Ishii A, Nonaka H, Aoyama S, Kase H, Kumazawa T. Indole derivatives as a new class of steroid 5 alpha-reductase inhibitors. J Med Chem. 1996 Dec 20;39(26):5047-52. PubMed PMID: 8978835.
5: Nagamoto A, Noguchi K, Murai T, Kinoshita Y. Significant role of 5 alpha-reductase on feedback effects of androgen in rat anterior pituitary cells demonstrated with a nonsteroidal 5 alpha-reductase inhibitor ONO-3805. J Androl. 1994 Nov-Dec;15(6):521-7. PubMed PMID: 7721654.
6: Takahashi O, Imai K, Watanabe K, Nakazawa Y, Nakata S, Kurita M, Saito Y, Kubota H, Yamanaka H. [The effect of sodium-4-[2-(2,3-dimethyl-4-[1-(4- isobutylphenyl)ethoxy]benzolamino)phenoxy] butyrate (ONO-3805) and antiandrogenic agents on the rat accessory sex organs]. Hinyokika Kiyo. 1992 Mar;38(3):305-10. Japanese. PubMed PMID: 1381863.
7: Imai K, Takahashi O, Watanabe K, Nakazawa Y, Nakata S, Yamanaka H. [The effects of antiprostatic agents on the accessory sex organs of rats treated with adrenal androgens]. Hinyokika Kiyo. 1991 Dec;37(12):1669-76. Japanese. PubMed PMID: 1785391.
